| Title: |
Factors associated with pre-treatment HIV RNA: Application for the use of abacavir and rilpivirine as the first-line regimen for HIV-infected patients in resource-limited settings |
| Authors: |
Kiertiburanakul, S; Boettiger, D; Ng, OT; Kinh, N; Merati, TP; Avihingsanon, A; Wong, WW; Lee, MP; Chaiwarith, R; Kamarulzaman, A; Kantipong, P; Zhang, FJ; Choi, JY; Kumarasamy, N; Ditangco, R; Cuong, DD; Oka, S; Sim, BLH; Ratanasuwan, W; Ly, PS; Yunihastuti, E; Pujari, S; Ross, JL; Law, M; Sungkanuparph, S; Khol, V; Zhao, HX; Han, N; Li, PCK; Lam, W; Chan, YT; Saghayam, S; Ezhilarasi, C; Joshi, K; Gaikwad, S; Chitalikar, A; Wirawan, DN; Yuliana, F; Imran, D; Widhani, A; Tanuma, J; Nishijima, T; Na, S; Kim, JM; Gani, YM; David, R; Syed Omar, SF; Ponnampalavanar, S; Azwa, I; Uy, E; Bantique, R; Ku, WW; Wu, PC; Lim, PL; Lee, LS; Ohnmar, PS; Gatechompol, S; Phanuphak, P; Phadungphon, C; Chumla, L; Sanmeema, N; Sirisanthana, T; Kotarathititum, W; Praparattanapan, J; Kambua, P; Sriondee, R; Nguyen, KV; Bui, HV; Nguyen, DTH; An, NV; Luan, NT; Sohn, AH; Petersen, B; Cooper, DA; Jiamsakul, A; Cooper, David; Han, Anna |
| Source: |
urn:ISSN:1742-6405 ; AIDS Research and Therapy, 14, 1, 27 |
| Publisher Information: |
Springer Nature |
| Publication Year: |
2017 |
| Collection: |
UNSW Sydney (The University of New South Wales): UNSWorks |
| Subject Terms: |
3207 Medical Microbiology; 32 Biomedical and Clinical Sciences; HIV/AIDS; Infectious Diseases; Infection; 3 Good Health and Well Being; Adult; Anti-HIV Agents; Antiretroviral Therapy; Highly Active; Asia; Decision Support Techniques; Developing Countries; Dideoxynucleosides; Female; HIV Infections; Humans; Male; Prospective Studies; RNA; Viral; Rilpivirine; Viral Load; Abacavir; HIV RNA; Model; Prediction; TREAT Asia HIV Observational Databases (TAHOD); anzsrc-for: 3207 Medical Microbiology; anzsrc-for: 32 Biomedical and Clinical Sciences |
| Description: |
Background: Abacavir and rilpivirine are alternative antiretroviral drugs for treatment-naïve HIV-infected patients. However, both drugs are only recommended for the patients who have pre-treatment HIV RNA |
| Document Type: |
article in journal/newspaper |
| Language: |
unknown |
| Relation: |
https://hdl.handle.net/1959.4/unsworks_53307 |
| DOI: |
10.1186/s12981-017-0151-1 |
| Availability: |
https://hdl.handle.net/1959.4/unsworks_53307; https://doi.org/10.1186/s12981-017-0151-1 |
| Rights: |
open access ; https://purl.org/coar/access_right/c_abf2 ; CC BY ; https://creativecommons.org/licenses/by/4.0/ |
| Accession Number: |
edsbas.80FF6478 |
| Database: |
BASE |